Health care costs, utilization and patterns of care following lyme disease

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Adrion, Emily R ^a   Aucott, John ^b   Lemke, Klaus W ^a   Weiner, Jonathan P ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTHROPATHY; ARTICLE; CHILD; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; DISEASE ASSOCIATION; FATIGUE; FEMALE; HEALTH CARE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; NEWBORN; PERIPHERAL NEUROPATHY; POST TREATMENT LYME DISEASE SYMPTOM; RETROSPECTIVE STUDY; RISK ASSESSMENT; UNITED STATES; ADOLESCENT; ECONOMICS; HEALTH CARE DELIVERY; INFANT; MIDDLE AGED; PRESCHOOL CHILD; UTILIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DELIVERY OF HEALTH CARE; FEMALE; HEALTH CARE COSTS; HUMANS; INFANT; INFANT, NEWBORN; LYME DISEASE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 84922367990     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0116767     Document Type: Article

References (27)

1. Stanek G, Wormser GP, Gray J, Strle F (2012) Lyme borreliosis. Lancet 379(9814): 461-73. doi: 10. 1016/S0140-6736(11)60103-7 PMID: 21903253.
2. Bacon RM, Kugeler KJ, Mead PS (2008) Surveillance for Lyme disease-United States, 1992-2006. MMWR 57:1-9. PMID: 19052530.
3. Centers for Disease Control and Prevention (2012) Reported Cases of Lyme Disease by Year, United States, 1996-2010. Available: http://www.cdc.gov/lyme/stats/chartstables/casesbyyear.html. Accessed 2013 July 16.
4. Hinckley AF, Connally NP, Meek JI, Johnson BJ, Kemperman MM, et al. (2014) Lyme Disease Testing by Large Commercial Laboratories in the United States. Clin Infect Dis 59(5): 676-681. doi: 10.1093/cid/ciu397 PMID: 24879782.
5. Centers for Disease Control and Prevention (2013) Notice to Readers: Final 2012 Reports of Nationally Notifiable Infectious Diseases. MMWR 62:669-82. PMID: 24133698.
6. Steere AC (2001) Lyme Disease. N Engl J Med 345(2):115-25. PMID: 11450660.
7. Centers for Disease Control and Prevention (2013) Post-Treatment Lyme Disease Syndrome. Available: http://www.cdc.gov/lyme/postLDS/index.html. Accessed July 2013 16.
8. Aucott JN, Rebman AW, Crowder LA, Kortte KB (2013) Post-Treatment Lyme Disease Syndrome symptomatology: Is there something here? Qual Life Res 22(1):75-84. PMID: 22294245.
9. Shadick NA, Phillips CB, Sangha O, Logigian EL, Kaplan RF, et al. (1999) Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease. Ann Intern Med 131(12):919-26. PMID: 10610642.
10. Fallon BA, Keilp JG, Corbera KM, Petkova E, Britton CB, et al. (2008) A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology 70(13):992-1003. PMID: 17928580.
11. Klempner MS, Hu LT, Evans J, Schmid CH, Johnson GM, et al. (2001) Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 345 (2):85-92. PMID: 11450676.
12. Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, et al. (2006) The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Disease Society of America. Clin Infect Dis 43(9):1089-134. PMID: 17029130.
13. Aguero-Rosenfeld ME, Nowakowski J, Bittker S, Cooper D, Nadelman RB, Wormser GP (1996) Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol 34(1):1-9. PMID: 8748261.
14. Aucott JN, Seifter A, Rebman AW (2012) Probable late Lyme disease: A variant manifestation of untreated Borrelia burgdorferi infection. BMC Infectious Diseases 12:173. PMID: 22853630.
15. Joss AW, Davidson MM, Ho-Yen DO, Ludbrook A (2003) Lyme disease-what is the cost for Scotland? Public Health 117(4): 264-73. PMID: 12966749.
16. Henningsson AJ, Malmvall BE, Ernerudh J, Matussek A, Forsberg P (2010) Neuroborreliosis-an epidemiological, clinical and healthcare cost study from an endemic area in the south-east of Sweden. Clin Microbiol Infect 16(8):1245-51. doi: 10.1111/j.1469-0691.2009.03059.x PMID: 19793326.
17. Maes E, Lecomte P, Ray N (1998) A cost-of-illness study of Lyme disease in the United States. Clin Ther 20(5):993-1008. PMID: 9829450.
18. Magid D, Schwartz B, Craft J, Schwartz JS (1992) Prevention of Lyme disease after tick bites. A cost-effectiveness analysis. N Engl J Med 327(8):534-41. PMID: 1298217.
19. Vanderhoof IT and Vanderhoof-Forschner KM (1993) Lyme Disease: The Cost to Society. Contingencies 42-8.
20. Zhang X, Meltzer MI, Pena CA, Hopkins AB, Wroth L, Fix AD (2006) Economic Impact of Lyme Disease. Emerging Infect Dis 12(4):653-60. PMID: 16704815.
21. Muller I, Freitag MH, Poggensee G (2012) Evaluating frequency, diagnostic quality, and cost of Lyme borreliosis testing in Germany: A retrospective model analysis. Clin Dev Immunol 595427.
22. Strickland GT, Karp AC, Mathews A, Pena CA (1997) Utilization and cost of serologic tests for Lyme disease in Maryland. J Infect Dis 176(3):819-21. PMID: 9291343.
23. Ley C, Le C, Olshen EM, Reingold AL (1994) The use of serologic tests for Lyme disease in a prepaid health plan in California. JAMA 271(6):460-3. PMID: 8080498.
24. Johns Hopkins School of Public Health. The Johns Hopkins ACG (R) System, Version 10. http://acg.jhsph.org. Accessed July 2013.
25. Krupp LB, Hyman LG, Grimson R, Coyle PK, Melville P, et al. (2003) Study and treatment of post Lyme disease (STOP-LD): A randomized double masked clinical trial. Neurology 60:1923-1930. PMID: 12821734.
26. Feder HM, Johnson BJB, O'Connell S, Shapiro ED, Steere AC, et al. (2007) A critical appraisal of "Chronic Lyme disease". N Engl J Med 357(14):1422-1430. PMID: 17914043.
27. Johnson L, Aylward A, Stricker RB (2011) Healthcare access and burden of care for patients with Lyme disease: A large United States survey. Health Policy 102(1):64-71. doi: 10.1016/j.healthpol.2011.05. 007 PMID: 21676482.